Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species

Clinical Microbiology and Infection

Volumn 6, Issue 4, 2000, Pages 195-201

  Kronvall, G ^a,c   Holst, E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotic susceptibility testing; Calibration; Disk diffusion test; Interpretive zone breakpoint; Quality control; Regression line; Trovafloxacin susceptibility

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; CALIBRATION; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; FINEGOLDIA MAGNA; PEPTOSTREPTOCOCCUS;

EID: 0034174697     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00031.x     Document Type: Article

References (37)

1. In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone
2. In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of Gram-positive bacteria
3. The in-vitro activity of CP-99,219, a new naphthyridone antimicrobial agent: A comparison with fluoroquinolone agents
4. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes
5. Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections
6. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: Review of current information on efficacy and safety
7. Anaerobic susceptibility tests: Differences between disc diffusion, agar dilution and broth microdilution test results
8. Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria
9. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing
10. In vitro testing of trovafloxacin according to the DIN 58940 guidelines evaluation of trovafloxacin discs and proposal of tentative din breakpoints
11. Probit Analysis. A statistical treatment of the sigmoid response curve
12. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance
13. Antibiotic disk diffusion testing revisited. Single strain regression analysis
14. Computer-generated plots of results of antimicrobial-susceptibility tests
15. Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae
16. Standardization of methods for conducting microbic sensitivity tests
17. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing
18. Determination of species-and laboratory-related interpretive breakpoints for doxycycline susceptibility testing using single-strain regression analysis
19. Interpretation of agar diffusion tests
20. Improving the accuracy of disc diffusion antibiotic susceptibility testing using species-related interpretive zone break-points
21. Calibration of disk diffusion antibiotic susceptibility testing. Calculation of species-related trovafloxacin interpretive zone breakpoints for the individual laboratory and aspects on the selection of disk potency
22. Types of interpretive errors in susceptibility testing
23. In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin
24. Comparison of the E-test and reference agar dilution method for susceptibility of gram-negative anaerobic organisms
25. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group
26. Comparison of E-test with conventional agar MICs for quinolones
27. Disk diffusion, agar dilution and the E-test for susceptibility testing of Corynebacterium jeikeium
28. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and E-test
29. Critical appraisal of E test for the detection of fluoroquinolone resistance
30. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: Comparison of methods
31. Evaluation of the E-test for susceptibility testing of anaerobic bacteria
32. A novel technique for direct quantification of antimicrobial susceptibility of microorganisms
33. Comparison of the E test (PDM epsilometer) and broth microdilution susceptibility tests for members of the Bacteroides fragilis group
34. Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria
35. Evaluation of the E-test for susceptibility testing of anaerobic bacteria